Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
13,405,064
-
Share change
-
+362,238
-
Total reported value
-
$295,579,870
-
Put/Call ratio
-
85%
-
Price per share
-
$22.05
-
Number of holders
-
125
-
Value change
-
-$1,422,350
-
Number of buys
-
57
-
Number of sells
-
82
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2016
As of 30 Jun 2016,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,405,064 shares.
The largest 10 holders included
BlackRock Fund Advisors, EAGLE ASSET MANAGEMENT INC, Krensavage Asset Management, LLC, FMR LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, VANGUARD GROUP INC, Fiera Capital Corp, GREAT POINT PARTNERS LLC, and SENZAR ASSET MANAGEMENT, LLC.
This page lists
125
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.